Exchange, Financial Services, Industry, Latvia, Medicine

International Internet Magazine. Baltic States news & analytics Thursday, 06.10.2022, 09:47

Grindex shareholders decide to delist the company

BC, Riga , 12.11.2020.Print version
Shareholders of Grindex pharmaceutical company at an extraordinary shareholders meeting today made a decision to delist the company from the regulated market, the company said in a statement to the Nasdaq Riga stock exchange.

The decision was made with the required majority of votes.

The total number of shares and voting shares in the company is 9,585,000.

As reported, Grindex turned over EUR 94.517 million in the first half of 2020, which is an increase of 37% against the same period a year ago, while the group's profit grew 68.4% y-o-y to EUR 12.867 mln.

Grindex belongs to the Lipmans family, whose Liplat Holding owns 94.16% of the pharmaceutical group's shares. Grindex is quoted on the Main List of Nasdaq Riga stock exchange.

    Search site